Baird Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $261M | Buy |
283,474
+7,380
| +3% | +$7.48M | 0.41% | 54 |
|
|
2025
Q4 | $297M | Buy |
276,094
+19,155
| +7% | +$18.3M | 0.46% | 47 |
|
|
2025
Q3 | $196M | Sell |
256,939
-9,630
| -4% | -$7.17M | 0.32% | 59 |
|
|
2025
Q2 | $208M | Buy |
266,569
+5,851
| +2% | +$4.55M | 0.36% | 55 |
|
|
2025
Q1 | $215M | Sell |
260,718
-2,329
| -0.9% | -$1.94M | 0.41% | 52 |
|
|
2024
Q4 | $203M | Sell |
263,047
-13,021
| -5% | -$10.8M | 0.39% | 53 |
|
|
2024
Q3 | $245M | Buy |
276,068
+13,462
| +5% | +$12.1M | 0.48% | 42 |
|
|
2024
Q2 | $238M | Buy |
262,606
+24,979
| +11% | +$20M | 0.49% | 41 |
|
|
2024
Q1 | $185M | Buy |
237,627
+10,974
| +5% | +$7.81M | 0.39% | 52 |
|
|
2023
Q4 | $132M | Buy |
226,653
+11,124
| +5% | +$6.49M | 0.3% | 67 |
|
|
2023
Q3 | $116M | Buy |
215,529
+14,653
| +7% | +$7.55M | 0.32% | 70 |
|
|
2023
Q2 | $94.2M | Sell |
200,876
-28,058
| -12% | -$11.8M | 0.25% | 90 |
|
|
2023
Q1 | $78.6M | Buy |
228,934
+4,478
| +2% | +$1.51M | 0.19% | 117 |
|
|
2022
Q4 | $82.1M | Buy |
224,456
+5,079
| +2% | +$1.8M | 0.22% | 100 |
|
|
2022
Q3 | $70.9M | Sell |
219,377
-10,601
| -5% | -$3.36M | 0.21% | 116 |
|
|
2022
Q2 | $74.6M | Sell |
229,978
-27,832
| -11% | -$8.35M | 0.21% | 109 |
|
|
2022
Q1 | $73.8M | Sell |
257,810
-5,819
| -2% | -$1.5M | 0.18% | 131 |
|
|
2021
Q4 | $72.8M | Buy |
263,629
+6,376
| +2% | +$1.62M | 0.17% | 144 |
|
|
2021
Q3 | $59.4M | Sell |
257,253
-5,269
| -2% | -$1.3M | 0.15% | 167 |
|
|
2021
Q2 | $60.3M | Sell |
262,522
-204
| -0.1% | -$41K | 0.16% | 167 |
|
|
2021
Q1 | $49.1M | Sell |
262,726
-14,322
| -5% | -$2.8M | 0.14% | 178 |
|
|
2020
Q4 | $46.8M | Buy |
277,048
+7,832
| +3% | +$1.17M | 0.14% | 175 |
|
|
2020
Q3 | $39.8M | Buy |
269,216
+16,142
| +6% | +$2.5M | 0.14% | 179 |
|
|
2020
Q2 | $41.5M | Sell |
253,074
-13,939
| -5% | -$2.14M | 0.16% | 167 |
|
|
2020
Q1 | $37M | Sell |
267,013
-14,668
| -5% | -$2.02M | 0.17% | 155 |
|
|
2019
Q4 | $37M | Buy |
281,681
+812
| +0.3% | +$94.1K | 0.13% | 185 |
|
|
2019
Q3 | $31.4M | Sell |
280,869
-266
| -0.1% | -$29.6K | 0.12% | 197 |
|
|
2019
Q2 | $31.1M | Buy |
281,135
+73,153
| +35% | +$8.61M | 0.12% | 196 |
|
|
2019
Q1 | $27M | Sell |
207,982
-1,465
| -0.7% | -$178K | 0.16% | 173 |
|
|
2018
Q4 | $24.2M | Buy |
209,447
+16,666
| +9% | +$1.86M | 0.16% | 164 |
|
|
2018
Q3 | $20.7M | Buy |
192,781
+34,253
| +22% | +$3.42M | 0.13% | 194 |
|
|
2018
Q2 | $13.5M | Sell |
158,528
-29,808
| -16% | -$2.45M | 0.09% | 249 |
|
|
2018
Q1 | $14.6M | Sell |
188,336
-70,702
| -27% | -$5.69M | 0.1% | 226 |
|
|
2017
Q4 | $21.9M | Sell |
259,038
-7,064
| -3% | -$601K | 0.16% | 171 |
|
|
2017
Q3 | $22.8M | Sell |
266,102
-900
| -0.3% | -$73.8K | 0.17% | 158 |
|
|
2017
Q2 | $22M | Buy |
267,002
+25,721
| +11% | +$2.1M | 0.17% | 161 |
|
|
2017
Q1 | $20.3M | Buy |
241,281
+67,000
| +38% | +$5.37M | 0.16% | 168 |
|
|
2016
Q4 | $12.8M | Buy |
174,281
+53,769
| +45% | +$4M | 0.11% | 200 |
|
|
2016
Q3 | $9.67M | Buy |
120,512
+1,260
| +1% | +$101K | 0.09% | 242 |
|
|
2016
Q2 | $9.43M | Buy |
119,252
+4,444
| +4% | +$335K | 0.09% | 233 |
|
|
2016
Q1 | $8.27M | Sell |
114,808
-7,979
| -6% | -$604K | 0.08% | 255 |
|
|
2015
Q4 | $10.3M | Buy |
122,787
+26,460
| +27% | +$2.2M | 0.1% | 206 |
|
|
2015
Q3 | $8.06M | Sell |
96,327
-8,947
| -8% | -$755K | 0.09% | 232 |
|
|
2015
Q2 | $8.79M | Buy |
+105,274
| New | +$8.02M | 0.09% | 231 |
|
Other funds holding LLY
VCM
VPM
Baird Financial Group's LLY Position: Q1 2026 in Review
Baird Financial Group increased its Eli Lilly (LLY) stake by 2.7% in Q1 2026, buying an estimated $7.48M and bringing the position to 283,474 shares worth $261M. The position accounts for 0.41% of the portfolio, ranked #54.
Baird Financial Group first reported a position in LLY in Q2 2015 and has held it in 44 quarters since. The position peaked at $297M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Baird Financial Group held 283,474 shares of Eli Lilly worth $261M as of Q1 2026.
- Baird Financial Group bought 7,380 Eli Lilly shares in Q1 2026, an estimated $7.48M.
- Eli Lilly made up 0.41% of Baird Financial Group's portfolio in Q1 2026, its #54 holding.
- Baird Financial Group first reported a position in Eli Lilly in Q2 2015 and has held it in 44 quarters since.
- Baird Financial Group's Eli Lilly position peaked at $297M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.